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Editor’s Choice
Negotiating the minefield of  
‘evidence-based’ medicine
In two stories this month, Izindaba reports on how easily we can be 
fooled by the catch-all phrase ‘evidence-based medicine’, and gives the 
actual (not manipulated or misrepresented) science behind a seemingly 
esoteric therapeutic tool called ‘mindfulness’.[1,2] The first comes 
from a presentation by Stellenbosch ethicist Professor Keymanthri 
Moodley at the 16th National Family Practitioners Conference in 
Observatory, Cape Town, last month, and the second from a talk at the 
same conference by Dr Simon Whitesman, a trailblazer in integrative 
medicine in South Africa. Whitesman cited some compelling magnetic 
resonance imaging studies on the meditating brains of veteran monks, 
plus an Italian trial comparing the metabolic complications in a cohort 
of diabetic patients under the care of highly empathic physicians versus 
those in a cohort seeing physicians with moderate or low empathy 
scores. The results may nudge some of us towards ‘ubuntu-like’ 
introspection that could do our practices (and well-being) a great deal 
of good, not to mention helping us serve our patients better.
Muckart offers additional, harder, insights into medicine as (in 
Osler’s words) ‘a science of uncertainty and an art of probability’, and 
reminds us in ‘Evidence-based medicine – are we boiling the frog?’[3] 
that ‘evidence is population based and may not be applicable to the 
individual, and blind adherence to this concept may cause harm. We 
must not abandon clinical experience and judgement in favour of a 
series of inanimate data points.’
Diabetes care in South Africa –  
two ends of the spectrum
An editorial[4] from two diabetologists contextualises two papers[5,6] 
on management of type 1 diabetes. One deals with a group of well-
controlled young people who, receiving their care in the private sector, 
have access to the new therapeutic agents, are provided with home 
blood glucose testing apparatus, and are guided by multidisciplinary 
diabetes care teams. The other reports on outcomes in a less fortunate 
group of patients treated in the public sector who use inexpensive 
insulin with little or no access to self-monitoring of blood glucose.
In Africa, diabetes is fast emerging as an important non-
communicable disease, and the ‘where’ of diabetes care has a powerful 
influence on outcomes. A rise in postprandial glucose is an independent 
risk factor for cardiovascular events and a predictor of macro- and 
microvascular disease. Diabetic retinopathy (DR) offers a ‘window’ 
on the microvascular system of individual diabetics. A Forum article 
informs us of a practical and pragmatic screening programme for 
DR developed by the Ophthalmological Society of Southern Africa, 
aimed at catching patients at primary care level and referring them for 
specialist treatment before sight is lost.[7]
Prevention of co-enrolment in clinical 
trials in South Africa
HIV-positive patients can be lured into simultaneously enrolling in 
more than one HIV treatment trial, believing that they will receive 
better healthcare (the benefits accruing from study participation 
include free confidential HIV counselling and testing, complete 
blood tests, gynaecological examinations, family planning and 
referral for care to local hospitals) and greater financial reward. 
Participant co-enrolment threatens the validity of HIV studies and 
risks the health of participants (e.g. from drug toxicity). Harichund 
and colleagues from the HIV Prevention Research Unit, Medical 
Research Council, Durban,[8] have developed an elegant tool – not 
unlike that which we encounter on arrival in foreign countries – that 
uses fingerprint-based biometric technology to identify participants.
ENT – not just tonsils and grommets
An editorial[9] and three papers[10-12] offer insight into the practice of 
otorhinolaryngology in this country. 
Much in the news lately, and featured in the May SAMJ in the context 
of cancer of the cervix, oncogenic human papillomavirus (HPV type 16) 
is now linked to oropharyngeal squamous carcinoma, with a prevalence 
in oropharyngeal cancer, especially tonsillar cancer, as high as 90%.[9]
Chronic otitis media remains a vexing problem among our children, 
often present for years before definitive ENT treatment. Not surprisingly, 
there is a high complication rate. Some of the lateness of presentation 
may reflect the fact that treatment of chronic otorrhoea (CO) is 
protocol driven and generally initiated at primary healthcare level. CO 
is, moreover, difficult to treat, and until now there has been a lack of 
local studies focusing on the bacteriology and antimicrobial sensitivities. 
Meyer and colleagues[10] and Tiedt et al.[11] have shown that the most 
common organisms isolated were Proteus mirabilis and Pseudomonas 
aeruginosa. According to the current Department of Health guideline, 
amoxicillin (or co-trimoxazole for patients allergic to penicillin) is 
the recommended treatment. But amoxicillin is a poor choice of 
antibiotic, given that the organisms cultured were susceptible mainly 
to fluoroquinolones and aminoglycosides with topical fluoroquinolone 
eardrops; the latter are as effective as aminoglycoside drops and without 
risk of ototoxicity.
Over 80% of HIV-infected individuals will present with ENT symptoms. 
A prospective study among HIV-infected ENT outpatients[11] revealed 
that when all presenting conditions were classified according to the World 
Health Organization (WHO) stages I - V HIV disease classification, the 
top five manifestations were adenoid hypertrophy/hyperplasia (stage I), 
cervical lymphadenopathy (stage I), chronic suppurative otitis media 
(stage II), otitis media with effusion (stage II), and sensorineural hearing 
loss (stage II). The study is the only one to have documented parotid 
gland cystic enlargement, revealing that this is an early (WHO stage I or 
II) manifestation, when immunity is well preserved. Parotid enlargement 
is recognised as a stigma of HIV, and patients are motivated to seek a 
diagnosis and possible cosmetic treatment.
The good news is that, whereas a few years ago the clinic handled 
mainly advanced WHO stage IV manifestations and unusual 
opportunistic AIDS-related infections, these are now rarely seen. There 
is now better awareness of HIV/AIDS disease manifestations among 
patients, together with large-scale HIV counselling and testing services 
and a commendable national ARV public rollout programme.
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